Regulatory Affairs India - Marketing Authorisation in India/Arzneimittelzulassung in Indien
- The regulatory environment + regulators
- New drug registration regulation
- Generics drug registration
- Line extension, variation
India and China are lucrative markets for European pharmaceutical products. With more than 1 billion inhabitants each, they are the most populous countries in the world. But what are the requirements for a successful marketing authorisation (generics and NCEs)? In this seminar you will learn about
- clinical trials in these countries
- the drug registration procedures
- dossier requirements
- post-approval regulatory processes
and much more.
May we invite you to seize the opportunity to attend this meeting and get in touch with three industrial experts?
Termin
| Datum: | 14.03.2012 |
| Ort: | Steigenberger Metropolitan Poststr. 6 -60329 Frankfurt |
| Preis: | 890,00 EUR zzgl. MwSt. |
Zielgruppe
This seminar will be of benefit to all working in the pharmaceutical industry interested in marketing pharmaceuticals/medical devices in India.
Especially those working in regulatory affairs and business development will profit from the seminar.
Kontaktinformationen
Weitere Pharma-Seminare, die Sie interessieren könnten:
